Home » Newsletters » BioWorld Science

BioWorld Science

Jan. 20, 2021

View Archived Issues

ConserV and Lawrence Livermore National Laboratory collaborate on broad-spectrum coronavirus vaccine

Dosing begins in phase I/II study of TP-0184 as treatment of anemia in patients with MDS

GC-019-F autologous CAR T-cell therapy receives IND approval in China

First patient dosed in second phase II study of AD-109 in obstructive sleep apnea

FDA clears IND application for TERN-501 to be developed as treatment for NASH

European Commission approves Enhertu for HER2-positive breast cancer

Ivermectin found useful in patients with nonsevere COVID-19 disease

Bayer synthesizes new P2X3 receptor antagonists

New IL-17 modulators discovered at UCB

ZM-32, a novel muscone derivative that inhibits breast tumor angiogenesis in vivo

Shanghai Pharmaceuticals Holding patents Wee1-like protein kinase inhibitors

IMPACT Therapeutics identifies ATR kinase inhibitors

Organ-on-a-chip bests standard toxicity tests

Shanghai Jemincare Pharmaceuticals, Jiangxi Jemincare Group present factor XIa inhibitors

FDA accepts IND application for PBCAR19B for NHL

Targeting the cartilage EGFR pathway is a promising therapeutic strategy in OA

GPR68-PKC pathway protects the brain from acidosis-induced neuronal injury

Gemcitabine can be repurposed as anti-HEV agent, in particular for HEV-infected cancer patients

New SIRP-alpha antibodies inducing tumor cell phagocytosis without affecting T-cell functionality

Caladrius opens phase IIb trial of CLBS-16 for coronary microvascular dysfunction

Lixte and City of Hope enter agreement to study LB-100 in phase Ib study for extensive stage SCLC

Clinical hold for planned phase I/II trial of HST-003 for knee cartilage regeneration

LMR-101 ameliorates symptoms of epilepsy in rodents

Aclaris reports topline phase IIa data on ATI-450 for rheumatoid arthritis

FDA approves Verquvo for heart failure

Aptorum cleared to begin phase I study in Canada with ALS-4 for S. aureus infections

Popular Stories

Today's news in brief
BioWorld
Precision psychiatry beyond, or before, biomarkers
BioWorld
There is broad agreement that psychiatric diagnoses in their current form are not reflective of any underlying biology, and that this is one of the things...
ADPD 2026: Can we prevent dementia? Scientists quantify it
BioWorld
Neurodegenerative disease and cognitive decline cannot be explained by a single process. Beta-amyloid plaques, hyperphosphorylated tau, alpha-synuclein, activated...
Keros reports beneficial effects of RKER-065 in ALS model
BioWorld Science
Keros Therapeutics Inc. has presented data regarding their activin receptor ligand trap, RKER-065, for the inhibition of the activin/myostatin signaling axis.
First-in-class POLG activator restores mtDNA across mutations
BioWorld Science
Researchers from Pretzel Therapeutics Inc. presented preclinical data of PX-578, a first-in-class POLG activator aimed at restoring mtDNA replication and...